Key Developments: Techne Corp (TECH.O)

TECH.O on Nasdaq

61.20USD
9 Feb 2010
Price Change (% chg)

$0.01 (+0.02%)
Prev Close
$61.19
Open
$61.75
Day's High
$62.16
Day's Low
$60.95
Volume
179,773
Avg. Vol
170,698
52-wk High
$69.95
52-wk Low
$45.38

Research a stock:

Latest Key Developments

Techne Corporation Declares Dividend
Tuesday, 2 Feb 2010 08:00am EST 

Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.26 per share for the quarter ended December 31, 2009. The quarterly dividend will be payable February 26, 2010 to all common shareholders of record on February 12, 2010. Future cash dividends will be considered by the Board of Directors on a quarterly basis. 

Techne Corporation Declares Dividend
Thursday, 29 Oct 2009 04:00pm EDT 

Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.26 per share for the quarter ended September 30, 2009. The quarterly dividend will be payable November 23, 2009 to all common shareholders of record on November 9, 2009. 

Techne Corporation Declares Dividend
Tuesday, 4 Aug 2009 07:00am EDT 

Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.25 per share for the quarter ended June 30, 2009. The quarterly dividend will be payable August 31, 2009 to all common shareholders of record on August 17, 2009. Future cash dividends will be considered by the Board of Directors on a quarterly basis. 

Techne Corporation Declares Dividend; Announces Share Repurchase
Tuesday, 28 Apr 2009 07:01am EDT 

Techne Corporation announced that it has decided to pay a dividend of $0.25 per share for the quarter ended March 31, 2009. The quarterly dividend will be payable May 22, 2009 to all common shareholders of record on May 8, 2009. The Company's Board of Directors also authorized the repurchase of an additional $60 million of the Company's common stock in connection with its ongoing share repurchase program, which does not have an expiration date. Including the above amount, the total share repurchase authorization remaining is approximately $67.5 million 

Techne Corporation Declares Dividend
Tuesday, 3 Feb 2009 07:00am EST 

Techne Corporation announced that its Board of Directors has approved a dividend payment of $0.25 per share for the quarter ended December 31, 2008. The quarterly dividend will be payable February 27, 2009, to all common shareholders of record on February 13, 2009. 

Techne Corporation Declares Dividend
Thursday, 23 Oct 2008 04:30pm EDT 

Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.25 per share for the quarter ended September 30, 2008. The quarterly dividend will be payable November 17, 2008 to all common shareholders of record on November 3, 2008. 

Techne Corporation Comments On Long Term Sales Growth
Tuesday, 29 Apr 2008 07:02am EDT 

Techne Corporation announced that it expects long-term sales growth will be in a targeted range of 8% to 10%, excluding the effect of changes in exchange rates. 

Techne Corporation Reaffirms FY 2008 Revenue Outlook
Tuesday, 29 Jan 2008 07:00am EST 

Techne Corporation announced that for fiscal 2008, given current trends for specific products, it continues to target revenue growth in the range of 8% to 11%. The Company reported revenue of $223.48 million in fiscal 2007. According to Reuters Estimates, analysts are expecting the Company to report revenue of $244.23 million for fiscal 2008. 

Techne Corporation Announces Share Repurchase Authorization
Wednesday, 14 Nov 2007 07:00am EST 

Techne Corporation announced that its Board of Directors has authorized the repurchase of up to $150 million of the Company's outstanding common shares. 

Techne Corporation Acquires Fortron Bio Science, Inc.
Wednesday, 6 Jul 2005 07:00am EDT 

Techne Corporation announced that its R&D Systems subsidiary has acquired Fortron Bio Science, Inc., a developer and manufacturer of monoclonal and polyclonal antibodies, antigens and other biological reagents. R&D Systems simultaneously acquired BiosPacific, Inc., a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems (IVDs) and immunodiagnostic kits. All of the shares of privately-held Fortron and substantially all of the assets of privately-held BiosPacific were acquired for an aggregate $20.0 million in cash. R&D Systems also assumed certain liabilities of BiosPacific, and incurred transaction expenses. 

US-RESEARCH/ (NON-S&P500)

Regency Energy Goldman Sachs Cuts to neutral to buy, reports Partners Lp theflyonthewall.com --------------------------------------------------------------- --------------- Ryland Group Credit Suisse Cuts to neutral from outperform,

Research a stock: